The lack of a preventive vaccine, coupled with common unresponsiveness to treatment and coinfection with HIV, has made HCV a major threat to public health. The authors review in vitro and in vivo models that are being used to study HCV and to develop new treatments and preventive measures.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1038/laban0205-39 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!